Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933203 · ClinicalTrials.gov registry record
Genetic Biomarkers of Executive Stress
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 51
- Enrollment target
NCT02933203: Completed study, sponsored by Stanford University.
NCT02933203 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02933203 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to examine whether stress predicts telomere length in individuals who hold executive-level positions. Telomeres are the caps at the end of each strand of DNA that may affect how cells age. Subjects will complete an online survey/interview and provide one blood sample or saliva samples. The goal is to understand whether stress predicts genetic markers of longevity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02933203
The ClinicalTrials.gov registry entry for NCT02933203 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02933203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02933203 about?
NCT02933203 is a clinical study titled "Genetic Biomarkers of Executive Stress". The purpose of this study is to examine whether stress predicts telomere length in individuals who hold executive-level positions. Telomeres are the caps at the end of each strand of DNA that may affect how cells age. Subjects will complete an online survey/interview and provide one blood sample or ...
What is the current status of trial NCT02933203?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2015-10. Estimated completion is 2017-06.
Who is sponsoring clinical trial NCT02933203?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.